Access Bio Inc (950130) - Product Pipeline Analysis, 2019 Update
August 2019
46
About the Report
About the Report
Summary
Access Bio Inc (Access Bio) is a medical device company that research, develops, manufactures and markets in-vitro diagnostics tests, biosensor, and molecular diagnostic products. The company provides in vitro diagnostic technology such as immunochemical, biochemical and molecular products. It utilizes advanced lateral flow technology for the production of its point of care diagnostic products. Access Bio's products include malaria RDT, G6PD POCT, HPV screening and genotyping test, molecular diagnostics, and others. The company also develops technologies for regents processing. The company operates through its research and development; and production facility located in Seoul, Korea. It has presence in Ethiopia, the US and Korea. The company serves non-profit organizations and private companies. Access Bio is headquartered in Somerset, New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Access Bio Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Access Bio Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
Drucker Diagnostics LLC
ACON Laboratories Inc
20/20 GeneSystems Inc
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Access Bio Inc Company Overview
Access Bio Inc Company Snapshot
Access Bio Inc Pipeline Products and Ongoing Clinical Trials Overview
Access Bio Inc-Pipeline Analysis Overview
Access Bio Inc-Key Facts
Access Bio Inc-Major Products and Services
Access Bio Inc Pipeline Products by Development Stage
Access Bio Inc Pipeline Products Overview
All-in-One Sensor
All-in-One Sensor Product Overview
Biosensor-ACR
Biosensor-ACR Product Overview
Biosensor-CRP
Biosensor-CRP Product Overview
Biosensor-D-dimer
Biosensor-D-dimer Product Overview
CareUS HIV Rapid Diagnostic Test
CareUS HIV Rapid Diagnostic Test Product Overview
CareUS Zika Virus RDT Diagnostic Test
CareUS Zika Virus RDT Diagnostic Test Product Overview
ICT-FluCombo RDT
ICT-FluCombo RDT Product Overview
ICT-Influenza A&B RDT
ICT-Influenza A&B RDT Product Overview
ICT-Malaria RDT
ICT-Malaria RDT Product Overview
ICT-Scrub Typhus IgM RDT
ICT-Scrub Typhus IgM RDT Product Overview
Molecular Diagnostic Test-Avellino Corneal Dystrophy
Molecular Diagnostic Test-Avellino Corneal Dystrophy Product Overview
Molecular Diagnostic Test-CAH
Molecular Diagnostic Test-CAH Product Overview
Molecular Diagnostic Test-CHK RT-PCR
Molecular Diagnostic Test-CHK RT-PCR Product Overview
Molecular Diagnostic Test-DENV RT-PCR
Molecular Diagnostic Test-DENV RT-PCR Product Overview
Molecular Diagnostic Test-KIR
Molecular Diagnostic Test-KIR Product Overview
Molecular Diagnostic Test-STD RT-PCR
Molecular Diagnostic Test-STD RT-PCR Product Overview
Molecular Diagnostic Test-TB/NTM
Molecular Diagnostic Test-TB/NTM Product Overview
Rapid Diagnostic Test-Chikungunya
Rapid Diagnostic Test-Chikungunya Product Overview
Rapid Diagnostic Test-Pneumonia
Rapid Diagnostic Test-Pneumonia Product Overview
Rapid Diagnostic Test-Sickle Cell Anemia
Rapid Diagnostic Test-Sickle Cell Anemia Product Overview
Rapid Diagnostic Test-Troponin I
Rapid Diagnostic Test-Troponin I Product Overview
ROS Gene POCT-Sexually Transmitted Disease
ROS Gene POCT-Sexually Transmitted Disease Product Overview
RosGENE For Malaria
RosGENE For Malaria Product Overview
Rosus-Chlamydia TRF
Rosus-Chlamydia TRF Product Overview
Rosus-Influenza TRF
Rosus-Influenza TRF Product Overview
Access Bio Inc-Key Competitors
Access Bio Inc-Key Employees
Access Bio Inc-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Access Bio Inc, Recent Developments
Apr 29, 2019: Access Bio and Atomo Diagnostics announce they have developed the world's first integrated hepatitis C rapid test for self-testing
Jul 03, 2018: Wells Bio's Zika diagnostic kit receives WHO approval
Dec 02, 2016: Access Bio recieved a USD USD 3.7 million grant from the Bill & Melinda Gates Foundation
Aug 09, 2013: Access Bio To Establish Korean Subsidiary
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Access Bio Inc Pipeline Products by Equipment Type
Access Bio Inc Pipeline Products by Development Stage
List of Table
List of Tables
Access Bio Inc Pipeline Products and Ongoing Clinical Trials Overview
Access Bio Inc Pipeline Products by Equipment Type
Access Bio Inc Pipeline Products by Indication
Access Bio Inc, Key Facts
Access Bio Inc, Major Products and Services
Access Bio Inc Number of Pipeline Products by Development Stage
Access Bio Inc Pipeline Products Summary by Development Stage
All-in-One Sensor-Product Status
All-in-One Sensor-Product Description
Biosensor-ACR-Product Status
Biosensor-ACR-Product Description
Biosensor-CRP-Product Status
Biosensor-CRP-Product Description
Biosensor-D-dimer-Product Status
Biosensor-D-dimer-Product Description
CareUS HIV Rapid Diagnostic Test-Product Status
CareUS HIV Rapid Diagnostic Test-Product Description
CareUS Zika Virus RDT Diagnostic Test-Product Status
CareUS Zika Virus RDT Diagnostic Test-Product Description
ICT-FluCombo RDT-Product Status
ICT-FluCombo RDT-Product Description
ICT-Influenza A&B RDT-Product Status
ICT-Influenza A&B RDT-Product Description
ICT-Malaria RDT-Product Status
ICT-Malaria RDT-Product Description
ICT-Scrub Typhus IgM RDT-Product Status
ICT-Scrub Typhus IgM RDT-Product Description
Molecular Diagnostic Test-Avellino Corneal Dystrophy-Product Status
Molecular Diagnostic Test-Avellino Corneal Dystrophy-Product Description
Molecular Diagnostic Test-CAH-Product Status
Molecular Diagnostic Test-CAH-Product Description
Molecular Diagnostic Test-CHK RT-PCR-Product Status
Molecular Diagnostic Test-CHK RT-PCR-Product Description
Molecular Diagnostic Test-DENV RT-PCR-Product Status
Molecular Diagnostic Test-DENV RT-PCR-Product Description
Molecular Diagnostic Test-KIR-Product Status
Molecular Diagnostic Test-KIR-Product Description
Molecular Diagnostic Test-STD RT-PCR-Product Status
Molecular Diagnostic Test-STD RT-PCR-Product Description
Molecular Diagnostic Test-TB/NTM-Product Status
Molecular Diagnostic Test-TB/NTM-Product Description
Rapid Diagnostic Test-Chikungunya-Product Status
Rapid Diagnostic Test-Chikungunya-Product Description
Rapid Diagnostic Test-Pneumonia-Product Status
Rapid Diagnostic Test-Pneumonia-Product Description
Rapid Diagnostic Test-Sickle Cell Anemia-Product Status
Rapid Diagnostic Test-Sickle Cell Anemia-Product Description
Rapid Diagnostic Test-Troponin I-Product Status
Rapid Diagnostic Test-Troponin I-Product Description
ROS Gene POCT-Sexually Transmitted Disease-Product Status
ROS Gene POCT-Sexually Transmitted Disease-Product Description
RosGENE For Malaria-Product Status
RosGENE For Malaria-Product Description
Rosus-Chlamydia TRF-Product Status
Rosus-Chlamydia TRF-Product Description
Rosus-Influenza TRF-Product Status
Rosus-Influenza TRF-Product Description
Access Bio Inc, Key Employees
Access Bio Inc, Other Locations
Access Bio Inc, Subsidiaries
Glossary
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.